Your browser doesn't support javascript.
loading
Study to evaluate awareness about medication errors and impact of an educational intervention among healthcare personnel in a cancer hospital.
Kunwor, Puskar; Basyal, Bijaya; Pathak, Nabin; Vaidya, Pankaj; Shrestha, Sudip.
Afiliación
  • Kunwor P; Department of Clinical Pharmacy, Nepal Cancer Hospital and Research Center, Lalitpur, Nepal.
  • Basyal B; Pharmaceutical Sciences Program, School of Health and Allied Sciences, Faculty of Health Sciences, Pokhara University, Kaski, Nepal.
  • Pathak N; Pharmaceutical Sciences Program, School of Health and Allied Sciences, Faculty of Health Sciences, Pokhara University, Kaski, Nepal.
  • Vaidya P; Department of Hospital Pharmacy, Nepal Cancer Hospital and Research Center, Lalitpur, Nepal.
  • Shrestha S; Department of Medical Oncology, Nepal Cancer Hospital and Research Center, Lalitpur, Nepal.
J Oncol Pharm Pract ; : 10781552241235898, 2024 Feb 25.
Article en En | MEDLINE | ID: mdl-38404015
ABSTRACT

INTRODUCTION:

Medication errors (MEs) are preventable incidents that can result in harm to patients. Therefore, it is essential for healthcare professionals (HCPs) to be well-informed about MEs. This study aims to assess the awareness levels of HCPs and the impact of educational intervention on their understanding of MEs.

METHODS:

Responses to a 17-question structured, self-administered questionnaire assessing the awareness of HCPs regarding fundamental aspects of MEs, ME reporting systems, and their ability to make recommendations for improving the system for handling the MEs were collected both before and after two weeks of educational intervention administration.

RESULTS:

Of a total of 114 HCPs who initially participated in the study, six dropped following the intervention. The awareness regarding the Class A questionnaire was good in most physicians (60%), nurses (60%), and pharmacists (57%) before the intervention, which improved postintervention, with physicians (80%), nurses (32%), and pharmacists (78%) demonstrating excellent awareness. The awareness level in the Class B questionnaire was also improved to excellent in most physicians (70%), pharmacists (85%), and nurses (85%) following the intervention, while it was excellent only in 50%, 35%, and 1% of physicians, pharmacists, and nurses, respectively, preintervention. In the Class C questionnaire, most physicians (40%) and nurses (60%) had good awareness, while pharmacists (35%) demonstrated excellent awareness preintervention. Postintervention, most physicians (70%), nurses (77%), and pharmacists (64%) exhibited excellent awareness.

CONCLUSION:

Most oncology practice HCPs demonstrate a good to average level of awareness regarding MEs. Clinical pharmacists' educational interventions can significantly enhance awareness among HCPs concerning MEs.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: J Oncol Pharm Pract Asunto de la revista: FARMACIA Año: 2024 Tipo del documento: Article País de afiliación: Nepal

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: J Oncol Pharm Pract Asunto de la revista: FARMACIA Año: 2024 Tipo del documento: Article País de afiliación: Nepal